EvoEndo
PrivateLast Round
Series A
Extension
Apr 13, 2023
Total Funding Raised
$18.53M
Company Overview
EvoEndo operates in Healthcare & Life Sciences and is based in Grayslake, Illinois. Its latest recorded funding round was a Series A Extension round in April 2023.
EvoEndo is a healthtech company that develops a single-use endoscopy system for unsedated transnasal endoscopy procedures for pediatric and adult patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EvoEndo Comparables
Compare EvoEndo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IQ Endoscopes Limited | 82% | |
| Ambu A/S | 77% | |
| Cortex, Inc. | 74% |
For institutional investors. Book with your work email.
EvoEndo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 13, 2023 | ||||
| Grant | Oct 24, 2022 | ||||
| Series A | Apr 19, 2022 | ||||
| Seed | Jun 3, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EvoEndo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| American Gastroenterological Association GI Opportunity Fund 1 | Series A Extension |
| TLP Investment Partners | Seed, Series A |
| American Gastroenterological Association | Series A |
| Varia Ventures | Series A Extension |
| AdvaMed Accel | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2022
$8.4M round led by TLP Investment Partners
For institutional investors. Book with your work email.
EvoEndo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EvoEndo's valuation, stock price, and market status.
Is EvoEndo a public or private company?
EvoEndo is a private company.
What is the current stock price of EvoEndo?
EvoEndo is a private company, so its shares have no public market price. Caplight tracks EvoEndo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EvoEndo worth (valuation)?
Valuation information for EvoEndo is not publicly available.
Can I buy EvoEndo stock?
EvoEndo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EvoEndo's last funding round?
EvoEndo's most recent funding round was Series A Extension on April 13, 2023.
Who are the main investors in EvoEndo?
Key investors in EvoEndo include TLP Investment Partners.
Will EvoEndo IPO soon?
No public IPO plans have been announced for EvoEndo.
How can I track EvoEndo secondary market activity?
Caplight tracks bids, offers, and trades in EvoEndo's shares on secondary markets.